Moderna (MRNA) president sells 53,336 shares after option exercises
Rhea-AI Filing Summary
Moderna, Inc. President Stephen Hoge reported an exercise-and-sale transaction in company stock. On May 15, 2026, he exercised stock options to acquire a total of 53,336 shares of common stock at an exercise price of $19.15 per share and sold 53,336 shares of common stock at an average price of $48.40 per share in open-market transactions. The filing notes that the reported transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 13, 2025. After these transactions, Hoge directly held 1,477,997 shares of Moderna common stock, along with additional indirect holdings of 151,933 shares held by a family trust and 4,116 shares held through Valhalla, LLC.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 53,336 shares ($2,581,462)
Net Sell
7 txns
Insider
Hoge Stephen
Role
President
Sold
53,336 shs ($2.58M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 37,226 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 16,110 | $0.00 | -- |
| Exercise | Common Stock | 37,226 | $19.15 | $713K |
| Exercise | Common Stock | 16,110 | $19.15 | $309K |
| Sale | Common Stock | 53,336 | $48.40 | $2.58M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 74,452 shares (Direct);
Common Stock — 1,515,223 shares (Direct);
Common Stock — 4,116 shares (Indirect, By Valhalla, LLC)
Footnotes (1)
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. This option is fully vested and exercisable.
Key Figures
Shares sold: 53,336 shares
Sale price: $48.40 per share
Shares acquired via option exercise: 53,336 shares
+5 more
8 metrics
Shares sold
53,336 shares
Common stock sold on May 15, 2026 at $48.40
Sale price
$48.40 per share
Average price for 53,336 common shares sold
Shares acquired via option exercise
53,336 shares
Common shares from stock option exercises at $19.15
Option exercise price
$19.15 per share
Exercise price for stock options converted to common stock
Direct holdings after transactions
1,477,997 shares
Common stock directly owned by Stephen Hoge after May 15, 2026
Indirect trust holdings
151,933 shares
Common stock held by a family trust for spouse and children
Indirect LLC holdings
4,116 shares
Common stock held indirectly through Valhalla, LLC
10b5-1 plan adoption date
November 13, 2025
Date the Rule 10b5-1 trading plan governing this sale was adopted
Key Terms
Rule 10b5-1 trading plan, Section 16 beneficial ownership, Stock Option (Right to Buy), derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Section 16 beneficial ownership regulatory
"The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein."
Stock Option (Right to Buy) financial
"Security title is reported as Stock Option (Right to Buy) with an exercise price of $19.1500."
derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
indirect ownership financial
"Holdings are reported as indirect with nature of ownership By Trust and By Valhalla, LLC."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Moderna (MRNA) President Stephen Hoge report?
Stephen Hoge reported exercising stock options and selling Moderna shares. He acquired 53,336 common shares at a $19.15 exercise price and sold 53,336 shares at an average price of $48.40, all on May 15, 2026, under a Rule 10b5-1 plan.
What stock options did Stephen Hoge exercise in this Moderna (MRNA) Form 4?
Stephen Hoge exercised stock options covering 53,336 shares of Moderna common stock. The options had an exercise price of $19.15 per share and were reported as fully vested and exercisable at the time of the May 15, 2026 transactions.
Was Stephen Hoge’s Moderna (MRNA) stock sale part of a Rule 10b5-1 trading plan?
Yes. The filing states the reported transaction was effected under a Rule 10b5-1 trading plan adopted on November 13, 2025. Such plans pre-schedule trades, providing structure and reducing the significance of trade timing.
What indirect Moderna (MRNA) holdings are reported for Stephen Hoge?
The Form 4 reports 151,933 Moderna shares held by a trust for the benefit of Stephen Hoge’s spouse and children, and 4,116 shares held through Valhalla, LLC. Hoge disclaims Section 16 beneficial ownership of these securities except for any pecuniary interest.